Displaying items 73-84 of 147 » View wsbt.com items only< Previous 1 2 3 4 5 6 7 8 9 10 11-13 Next >
ReutersNEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds. Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...
Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...
Money & CompanyThe Securities and Exchange Commission has accused Stiefel Laboratories, a subsidiary of GlaxoSmithKline, and the subsidiary’s former chief executive of defrauding employees and other shareholders by buying back the company’s private stock...
HealthDoes your health care non-profit have an impact on the community? GlaxoSmithKline wants to know. The pharmaceutical company is holding its 16th annual IMPACT awards to recognize community-based nonprofits that provide access to healthcare for the...
Company Town21 Jump Street finishes on top of the box office. James Murdoch exits another board. Rosie O'Donnell hits the road....
ReutersLONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
ReutersSTOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...
ReutersZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
A do-it-yourself test for cervical cancer could help prevent thousands of cases of the disease in women who don't have easy or regular access to smear tests, scientists said Wednesday. The DIY test, which detects the human papillomavirus (HPV)...
ReutersLONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
Jan 10, 2012 |Story| CNN
Jan 23, 2012 |Story| Reuters
Apr 19, 2012 |Story| Baltimore Sun
Dec 12, 2011 | Los Angeles Times
Mar 6, 2012 | Allentown Morning Call
Mar 19, 2012 | Los Angeles Times
Sep 13, 2011 |Story| Reuters
Sep 25, 2011 |Story| Reuters
Sep 27, 2011 |Story| Chicago Tribune
Sep 20, 2011 |Story| Reuters
Nov 2, 2011 |Story| Reuters
Nov 24, 2011 |Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.